Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Aurobindo Pharma USA history
Aurobindo Pharma USA company history timeline
The commercial production of the pharmaceutical formulation unit was started in April of the year 1994.
Commercial production of the pharmaceutical formulation unit started in April.Aurobindo Pharma became a public company in 1995.
Aurobindo Pharma had gone public in 1995 by listing its shares in various stock exchanges in the country.
In the year 1998 the company had launched new formulations like auronim Suspension in the paediatric segment.
Launched two more drugs in 2001 namely Efavirenz (Viranz) and Nelfinavir (NELVEX) for the treatment of AIDS.
Ranit Pharma and Calc Private Ltd were amalgamated with APL as of 1st April 2002.
The State Labour Department of the Government of Andhra Pradesh awarded Aurobindo the ‘Best Management Award’ in 2005 for the Company’s contributions towards community development, harmonious employee relations and employee welfare.
During the year 2005-06 the company made a strategic entry with its generic formulations in the premium markets of USA & Europe participated in the PEPFAR program initiated by the Government of USA and consolidated its strengths in the less regulated and emerging markets.
The Hon'ble High Court of Andhra Pradesh has approved the scheme of arrangement for merger of APL Life Sciences and Senor Organics into the company and the utilisation of share premium account of the company during June of the year 2007.
As at June 13th of the year 2007 the Company unveiled their new Logo and Corporate Identity at a ceremony in Hyderabad.
The Board in its meeting held on 16 October 2020 decided to enter into a share purchase agreement to acquire 100% equity share capital of MViyes Pharma Ventures Private Limited.
During the FY2021the company has incorporated WYTELLS PHARMA PRIVATE LIMITED w.e.f 20 February 2021 as a subsidiary to Eugia Pharma Specialties Limited India.
At 1.79 million, demat accounts opened in June fewest since Feb 2021
Rate how well Aurobindo Pharma USA lives up to its initial vision.
Aurobindo Pharma USA jobs
Do you work at Aurobindo Pharma USA?
Is Aurobindo Pharma USA's vision a big part of strategic planning?
Aurobindo Pharma USA competitors
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Zydus Pharmaceuticals | 2005 | $500.0M | 179 | 3 |
| Cambrex | 1981 | $532.1M | 2,201 | 35 |
| CorePharma | 1995 | $15.0M | 200 | - |
| Teva Pharmaceuticals | 1901 | $16.5B | 4,999 | 184 |
| Qualitest Pharmaceuticals | 1983 | $230.0M | 7,500 | - |
| Aspen Pharma | - | $477.8M | 7,500 | - |
| Medivation | 2003 | $1.0B | 628 | - |
| ValueCentric | 2002 | $13.0M | 300 | - |
| SPARSH BIO-TECH PRIVATE LIMITED | 2004 | $12.9M | 125 | - |
| Dr. Reddy's Lab | 1984 | $2.1B | 75 | 12 |
Aurobindo Pharma USA history FAQs
Zippia gives an in-depth look into the details of Aurobindo Pharma USA, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Aurobindo Pharma USA. The employee data is based on information from people who have self-reported their past or current employments at Aurobindo Pharma USA. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Aurobindo Pharma USA. The data presented on this page does not represent the view of Aurobindo Pharma USA and its employees or that of Zippia.
Aurobindo Pharma USA may also be known as or be related to Aurobindo Pharma, Aurobindo Pharma USA, Aurobindo Pharma USA, Inc., Aurobindo Pharma Usa, Inc. and Aurobindo Pharmaceuticals USA Inc.